Coreceptor usage by HIV-1 and HIV-2 primary isolates: The relevance of CCR8 chemokine receptor as an alternative coreceptor

Virology

Volumn 408, Issue 2, 2010, Pages 174-182

  Calado, M ^a   Matoso, P ^a,f   Santos Costa, Q ^a,g   Espirito Santo, M ^a   Machado, J ^b   Rosado, L ^c   Antunes, F ^d   Mansinho, K ^e   Lopes, M M ^a   Maltez, F ^b   Santos Ferreira, M O ^a   Azevedo Pereira, J M ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b HOSPITAL CURRY CABRAL   (Portugal)

^c HOSPITAL DONA ESTEFÂNIA   (Portugal)

^d HOSPITAL DE SANTA MARIA   (Portugal)

^e HOSPITAL EGAS MONIZ   (Portugal)

^f INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^g INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

Antiretroviral therapy; CCR8; Cellular receptor; Chemokine receptor; Entry inhibitor; HIV coreceptor; HIV 1; HIV 2; Pathogenesis; Primary isolate

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS ENTRY; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 78149410393     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.09.020     Document Type: Article

References (74)

1. Azevedo-Pereira J.M., Santos-Costa Q., Mansinho K., Moniz-Pereira J. Identification and characterization of HIV-2 strains obtained from asymptomatic patients that do not use CCR5 or CXCR4 coreceptors. Virology 2003, 313(1):136-146.
2. Baba M., Nishimura O., Kanzaki N., Okamoto M., Sawada H., Iizawa Y., Shiraishi M., Aramaki Y., Okonogi K., Ogawa Y., Meguro K., Fujino M. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl Acad. Sci. USA 1999, 96(10):5698-5703.
3. Berger E.A., Doms R.W., Fenyo E.M., Korber B.T., Littman D.R., Moore J.P., Sattentau Q.J., Schuitemaker H., Sodroski J., Weiss R.A. A new classification for HIV-1. Nature 1998, 391(6664):240.
4. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17:657-700.
5. Berkowitz R.D., Beckerman K.P., Schall T.J., McCune J.M. CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J. Immunol. 1998, 161(7):3702-3710.
6. Berndt C., Mopps B., Angermuller S., Gierschik P., Krammer P.H. CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells. Proc. Natl Acad. Sci. USA 1998, 95(21):12556-12561.
7. Biard-Piechaczyk M., Robert-Hebmann V., Roland J., Coudronniere N., Devaux C. Role of CXCR4 in HIV-1-induced apoptosis of cells with a CD4+, CXCR4+ phenotype. Immunol. Lett. 1999, 70(1):1-3.
8. Bjorndal A., Deng H., Jansson M., Fiore J.R., Colognesi C., Karlsson A., Albert J., Scarlatti G., Littman D.R., Fenyo E.M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 1997, 71(10):7478-7487.
9. Bobardt M.D., Chatterji U., Selvarajah S., Van der Schueren B., David G., Kahn B., Gallay P.A. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J. Virol. 2007, 81(1):395-405.
10. Broder C.C., Jones-Trower A. Coreceptor use by primate Lentiviruses. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences Theoretical Biology and Biophysics Group 1999, 517-541. Los Alamos National Laboratory, Los Alamos, NM. C. Kuiken, B.T. Foley, B. Hahn, B. Korber, F. McCutchan, P.A. Marx, J.W. Mellors, J.I. Mullins, J. Sodroski, S. Wolinsky (Eds.).
11. Bron R., Klasse P.J., Wilkinson D., Clapham P.R., Pelchen-Matthews A., Power C., Wells T.N., Kim J., Peiper S.C., Hoxie J.A., Marsh M. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. J. Virol. 1997, 71(11):8405-8415.
12. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among Adolescents and Adults. MMWR. Morb. Mortal. Wkly. Rep. 41 (RR-17) 1992, 1-19. CDC.
13. Cilliers T., Nhlapo J., Coetzer M., Orlovic D., Ketas T., Olson W.C., Moore J.P., Trkola A., Morris L. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J. Virol. 2003, 77(7):4449-4456.
14. Cilliers T., Willey S., Sullivan W.M., Patience T., Pugach P., Coetzer M., Papathanasopoulos M., Moore J.P., Trkola A., Clapham P., Morris L. Use of alternate coreceptors on primary cells by two HIV-1 isolates. Virology 2005, 339(1):136-144.
15. Connor R.I., Ho D.D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 1994, 68(7):4400-4408.
16. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 1997, 185(4):621-628.
17. Dairaghi D.J., Fan R.A., McMaster B.E., Hanley M.R., Schall T.J. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J. Biol. Chem. 1999, 274(31):21569-21574.
18. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312(5996):763-767.
19. D'Ambrosio D., Iellem A., Bonecchi R., Mazzeo D., Sozzani S., Mantovani A., Sinigaglia F. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 1998, 161(10):5111-5115.
20. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273(5283):1856-1862.
21. Deng H.K., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997, 388(6639):296-300.
22. Donzella G.A., Schols D., Lin S.W., Este J.A., Nagashima K.A., Maddon P.J., Allaway G.P., Sakmar T.P., Henson G., De Clercq E., Moore J.P. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 1998, 4(1):72-77.
23. Edinger A.L., Hoffman T.L., Sharron M., Lee B., O'Dowd B., Doms R.W. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 1998, 249(2):367-378.
24. Fouchier R.A., Meyaard L., Brouwer M., Hovenkamp E., Schuitemaker H. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo. Virology 1996, 219(1):87-95.
25. Goya I., Gutiérrez J., Varona R., Kremer L., Zaballos A., Márquez G. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3. J. Immunol. 1998, 160(4):1975-1981.
26. Guillon C., van der Ende M.E., Boers P.H., Gruters R.A., Schutten M., Osterhaus A.D. Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities. J. Virol. 1998, 72(7):6260-6263.
27. Haque N.S., Fallon J.T., Taubman M.B., Harpel P.C. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood 2001, 97(1):39-45.
28. Haque N.S., Fallon J.T., Pan J.J., Taubman M.B., Harpel P.C. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood 2004, 103(4):1296-1304.
29. Herbein G., Van Lint C., Lovett J.L., Verdin E. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 1998, 72(1):660-670.
30. Horuk R., Hesselgesser J., Zhou Y., Faulds D., Halks-Miller M., Harvey S., Taub D., Samson M., Parmentier M., Rucker J., Doranz B.J., Doms R.W. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J. Biol. Chem. 1998, 273(1):386-391.
31. Inngjerdingen M., Damaj B., Maghazachi A.A. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J. Immunol. 2000, 164(8):4048-4054.
32. Isaacman-Beck J., Hermann E., Yi Y., Ratcliffe S., Mulenga J., Allen S., Hunter E., Derdeyn C., Collman R. Heterosexual transmission of HIV-1 Subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J. Virol. 2009, 83(16):8208-8220.
33. Jekle A., Keppler O.T., De Clercq E., Schols D., Weinstein M., Goldsmith M.A. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J. Virol. 2003, 77(10):5846-5854.
34. Jinno A., Shimizu N., Soda Y., Haraguchi Y., Kitamura T., Hoshino H. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection. Biochem. Biophys. Res. Commun. 1998, 243(2):497-502.
35. Kitchen S.G., Zack J.A. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J. Virol. 1997, 71(9):6928-6934.
36. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312(5996):767-768.
37. Lee S., Tiffany H.L., King L., Murphy P.M., Golding H., Zaitseva M.B. CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor. J. Virol. 2000, 74(15):6946-6952.
38. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86(3):367-377.
39. Liu H.Y., Soda Y., Shimizu N., Haraguchi Y., Jinno A., Takeuchi Y., Hoshino H. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses. Virology 2000, 278(1):276-288.
40. McKnight A., Dittmar M.T., Moniz-Periera J., Ariyoshi K., Reeves J.D., Hibbitts S., Whitby D., Aarons E., Proudfoot A.E., Whittle H., Clapham P.R. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J. Virol. 1998, 72(5):4065-4071.
41. Moore J.P., Kitchen S.G., Pugach P., Zack J.A. The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 2004, 20(1):111-126.
42. Morner A., Bjorndal A., Albert J., Kewalramani V.N., Littman D.R., Inoue R., Thorstensson R., Fenyo E.M., Bjorling E. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 1999, 73(3):2343-2349.
43. Mummidi S., Ahuja S.S., Gonzalez E., Anderson S.A., Santiago E.N., Stephan K.T., Craig F.E., O'Connell P., Tryon V., Clark R.A., Dolan M.J., Ahuja S.K. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med. 1998, 4(7):786-793.
44. Napolitano M., Zingoni A., Bernardini G., Spinetti G., Nista A., Storlazzi C.T., Rocchi M., Santoni A. Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. J. Immunol. 1996, 157(7):2759-2763.
45. Neil S.J., Aasa-Chapman M.M., Clapham P.R., Nibbs R.J., McKnight A., Weiss R.A. The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. J. Virol. 2005, 79(15):9618-9624.
46. Ohagen A., Devitt A., Kunstman K.J., Gorry P.R., Rose P.P., Korber B., Taylor J., Levy R., Murphy R.L., Wolinsky S.M., Gabuzda D. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J. Virol. 2003, 77(22):12336-12345.
47. Owen S.M., Ellenberger D., Rayfield M., Wiktor S., Michel P., Grieco M.H., Gao F., Hahn B.H., Lal R.B. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J. Virol. 1998, 72(7):5425-5432.
48. Pohlmann S., Krumbiegel M., Kirchhoff F. Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1. J. Gen. Virol. 1999, 80(Pt 5):1241-1251.
49. Reeves J.D., Hibbitts S., Simmons G., McKnight A., Azevedo-Pereira J.M., Moniz-Pereira J., Clapham P.R. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. J. Virol. 1999, 73(9):7795-7804.
50. Richman D.D., Bozzette S.A. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 1994, 169(5):968-974.
51. Roos R.S., Loetscher M., Legler D.F., Clark-Lewis I., Baggiolini M., Moser B. Identification of CCR8, the receptor for the human CC chemokine I-309. J. Biol. Chem. 1997, 272(28):17251-17254.
52. Rucker J., Edinger A.L., Sharron M., Samson M., Lee B., Berson J.F., Yi Y., Margulies B., Collman R.G., Doranz B.J., Parmentier M., Doms R.W. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 1997, 71(12):8999-9007.
53. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382(6593):722-725.
54. Samson M., Stordeur P., Labbe O., Soularue P., Vassart G., Parmentier M. Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor. Eur. J. Immunol. 1996, 26(12):3021-3028.
55. Santos-Costa Q., Mansinho K., Moniz-Pereira J., Azevedo-Pereira J.M. Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors. Virus Res. 2009, 142(1-2):41-50.
56. Shimizu N., Tanaka A., Oue A., Mori T., Ohtsuki T., Apichartpiyakul C., Uchiumi H., Nojima Y., Hoshino H. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV. AIDS 2009, 27(7):761-769.
57. Simmons G., Wilkinson D., Reeves J.D., Dittmar M.T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P.W., Weiss R.A., Clapham P.R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 1996, 70(12):8355-8360.
58. Simmons G., Reeves J.D., Hibbitts S., Stine J.T., Gray P.W., Proudfoot A.E., Clapham P.R. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol. Rev. 2000, 177:112-126.
59. Singh A., Besson G., Mobasher A., Collman R.G. Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood. J. Virol. 1999, 73(8):6680-6690.
60. Sol N., Ferchal F., Braun J., Pleskoff O., Treboute C., Ansart I., Alizon M. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J. Virol. 1997, 71(11):8237-8244.
61. Su L., Kaneshima H., Bonyhadi M.L., Lee R., Auten J., Wolf A., Du B., Rabin L., Hahn B.H., Terwilliger E., McCune J.M. Identification of HIV-1 determinants for replication in vivo. Virology 1997, 227(1):45-52.
62. Taylor J.R., Kimbrell K.C., Scoggins R., Delaney M., Wu L., Camerini D. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1. J. Virol. 2001, 75(18):8752-8760.
63. Tersmette M., Gruters R.A., de Wolf F., de Goede R.E., Lange J.M., Schellekens P.T., Goudsmit J., Huisman H.G., Miedema F. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 1989, 63(5):2118-2125.
64. Tiffany H.L., Lautens L.L., Gao J.L., Pease J., Locati M., Combadiere C., Modi W., Bonner T.I., Murphy P.M. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J. Exp. Med. 1997, 186(1):165-170.
65. van't Wout A.B., Blaak H., Ran L.J., Brouwer M., Kuiken C., Schuitemaker H. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. J. Virol. 1998, 72(6):5099-5107.
66. Vodros D., Thorstensson R., Doms R.W., Fenyo E.M., Reeves J.D. Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques. Virology 2003, 316(1):17-28.
67. Willey S.J., Reeves J.D., Hudson R., Miyake K., Dejucq N., Schols D., De Clercq E., Bell J., McKnight A., Clapham P.R. Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells. J. Virol. 2003, 77(11):6138-6152.
68. Xiao L., Rudolph D.L., Owen S.M., Spira T.J., Lal R.B. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 1998, 12(13):F137-F143.
69. Zaballos A., Varona R., Gutierrez J., Lind P., Marquez G. Molecular cloning and RNA expression of two new human chemokine receptor-like genes. Biochem. Biophys. Res. Commun. 1996, 227(3):846-853.
70. Zhang Y.J., Moore J.P. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?. J. Virol. 1999, 73(4):3443-3448.
71. Zhang L., He T., Talal A., Wang G., Frankel S.S., Ho D.D. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 1998, 72(6):5035-5045.
72. Zhang Y.J., Dragic T., Cao Y., Kostrikis L., Kwon D.S., Littman D.R., KewalRamani V.N., Moore J.P. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. J. Virol. 1998, 72(11):9337-9344.
73. Zhang Y., Lou B., Lal R.B., Gettie A., Marx P.A., Moore J.P. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J. Virol. 2000, 74(15):6893-6910.
74. Zingoni A., Soto H., Hedrick J.A., Stoppacciaro A., Storlazzi C.T., Sinigaglia F., D'Ambrosio D., O'Garra A., Robinson D., Rocchi M., Santoni A., Zlotnik A., Napolitano M. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 1998, 161(2):547-551.